|
|
Volumn 5, Issue 1, 2005, Pages 18-27
|
|
The management of myasthenia gravis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALENDRONIC ACID;
ANALGESIC AGENT;
ANTIBIOTIC AGENT;
AZATHIOPRINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM;
CHOLINERGIC RECEPTOR;
CHOLINESTERASE INHIBITOR;
CORTICOSTEROID DERIVATIVE;
CYCLOSPORIN;
FOLIC ACID;
IMMUNOGLOBULIN;
IMMUNOMODULATING AGENT;
IMMUNOSUPPRESSIVE AGENT;
LANSOPRAZOLE;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NONSTEROID ANTIINFLAMMATORY AGENT;
PREDNISOLONE;
PROPANTHELINE BROMIDE;
PYRIDOSTIGMINE;
VITAMIN D;
ABDOMINAL CRAMP;
BODY WEIGHT DISORDER;
BONE MARROW DEPRESSION;
BONE MARROW SUPPRESSION;
CATARACT;
CLINICAL TRIAL;
DEPRESSION;
DIABETES MELLITUS;
DIARRHEA;
DRUG DOSE REGIMEN;
DRUG POTENTIATION;
FLATULENCE;
HEPATITIS;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
INFECTION;
INSOMNIA;
KIDNEY DISEASE;
LIVER DYSFUNCTION;
LOW BIRTH WEIGHT;
LYMPHOCYTOPENIA;
MEGALOCYTOSIS;
MOOD DISORDER;
MUSCLE CRAMP;
MYASTHENIA GRAVIS;
NAUSEA;
OSTEOPOROSIS;
PARESTHESIA;
PATIENT CARE;
PEPTIC ULCER;
PLASMAPHERESIS;
PSYCHOSIS;
PTOSIS;
REMISSION;
REVIEW;
SYMPTOMATOLOGY;
TERATOGENICITY;
THYMECTOMY;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TREATMENT PLANNING;
TREMOR;
URINE INCONTINENCE;
VOMITING;
|
|
EID: 14144253110
PISSN: 14747758
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1474-7766.2005.00280.x Document Type: Review |
|
Times cited : (7)
|
|
References (6)
|
